Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $12.91 billion. The enterprise value is $11.90 billion.
| Market Cap | 12.91B |
| Enterprise Value | 11.90B |
Important Dates
The last earnings date was Wednesday, February 11, 2026, after market close.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 100.36 million shares outstanding. The number of shares has decreased by -1.16% in one year.
| Current Share Class | 100.36M |
| Shares Outstanding | 100.36M |
| Shares Change (YoY) | -1.16% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | 1.22% |
| Owned by Institutions (%) | 96.72% |
| Float | 99.07M |
Valuation Ratios
The trailing PE ratio is 27.54 and the forward PE ratio is 16.19. NBIX's PEG ratio is 0.82.
| PE Ratio | 27.54 |
| Forward PE | 16.19 |
| PS Ratio | 4.51 |
| Forward PS | 3.73 |
| PB Ratio | 3.96 |
| P/TBV Ratio | 3.97 |
| P/FCF Ratio | 17.24 |
| P/OCF Ratio | 16.49 |
| PEG Ratio | 0.82 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.85, with an EV/FCF ratio of 15.90.
| EV / Earnings | 24.87 |
| EV / Sales | 4.16 |
| EV / EBITDA | 17.85 |
| EV / EBIT | 18.70 |
| EV / FCF | 15.90 |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.14.
| Current Ratio | 3.39 |
| Quick Ratio | 2.92 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.65 |
| Debt / FCF | 0.63 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.38% and return on invested capital (ROIC) is 18.73%.
| Return on Equity (ROE) | 16.38% |
| Return on Assets (ROA) | 9.53% |
| Return on Invested Capital (ROIC) | 18.73% |
| Return on Capital Employed (ROCE) | 16.37% |
| Weighted Average Cost of Capital (WACC) | 5.76% |
| Revenue Per Employee | $1.43M |
| Profits Per Employee | $239,300 |
| Employee Count | 2,000 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 16.90 |
Taxes
In the past 12 months, NBIX has paid $226.80 million in taxes.
| Income Tax | 226.80M |
| Effective Tax Rate | 32.15% |
Stock Price Statistics
The stock price has increased by +12.58% in the last 52 weeks. The beta is 0.31, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +12.58% |
| 50-Day Moving Average | 138.92 |
| 200-Day Moving Average | 136.04 |
| Relative Strength Index (RSI) | 40.41 |
| Average Volume (20 Days) | 1,291,057 |
Short Selling Information
The latest short interest is 3.34 million, so 3.33% of the outstanding shares have been sold short.
| Short Interest | 3.34M |
| Short Previous Month | 3.50M |
| Short % of Shares Out | 3.33% |
| Short % of Float | 3.37% |
| Short Ratio (days to cover) | 3.03 |
Income Statement
In the last 12 months, NBIX had revenue of $2.86 billion and earned $478.60 million in profits. Earnings per share was $4.67.
| Revenue | 2.86B |
| Gross Profit | 1.79B |
| Operating Income | 636.50M |
| Pretax Income | 705.40M |
| Net Income | 478.60M |
| EBITDA | 666.60M |
| EBIT | 636.50M |
| Earnings Per Share (EPS) | $4.67 |
Balance Sheet
The company has $1.48 billion in cash and $471.30 million in debt, with a net cash position of $1.01 billion or $10.05 per share.
| Cash & Cash Equivalents | 1.48B |
| Total Debt | 471.30M |
| Net Cash | 1.01B |
| Net Cash Per Share | $10.05 |
| Equity (Book Value) | 3.25B |
| Book Value Per Share | 32.50 |
| Working Capital | 1.78B |
Cash Flow
In the last 12 months, operating cash flow was $782.70 million and capital expenditures -$34.00 million, giving a free cash flow of $748.70 million.
| Operating Cash Flow | 782.70M |
| Capital Expenditures | -34.00M |
| Free Cash Flow | 748.70M |
| FCF Per Share | $7.46 |
Margins
Gross margin is 62.67%, with operating and profit margins of 22.25% and 16.73%.
| Gross Margin | 62.67% |
| Operating Margin | 22.25% |
| Pretax Margin | 24.66% |
| Profit Margin | 16.73% |
| EBITDA Margin | 23.30% |
| EBIT Margin | 22.25% |
| FCF Margin | 26.17% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.16% |
| Shareholder Yield | 1.16% |
| Earnings Yield | 3.71% |
| FCF Yield | 5.80% |
Analyst Forecast
The average price target for NBIX is $175.95, which is 36.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $175.95 |
| Price Target Difference | 36.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 9.94% |
| EPS Growth Forecast (5Y) | 27.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 7.33 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.33 |
| Piotroski F-Score | 5 |